These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25723571)

  • 1. MDM2-mediated degradation of p14ARF: a novel mechanism to control ARF levels in cancer cells.
    Vivo M; Matarese M; Sepe M; Di Martino R; Festa L; Calabrò V; La Mantia G; Pollice A
    PLoS One; 2015; 10(2):e0117252. PubMed ID: 25723571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics in the p53-Mdm2 ubiquitination pathway.
    Brooks CL; Gu W
    Cell Cycle; 2004 Jul; 3(7):895-9. PubMed ID: 15254415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal MDMX degradation in tumor cells due to ARF deficiency.
    Li X; Gilkes D; Li B; Cheng Q; Pernazza D; Lawrence H; Lawrence N; Chen J
    Oncogene; 2012 Aug; 31(32):3721-32. PubMed ID: 22120712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.
    Vivo M; Ranieri M; Sansone F; Santoriello C; Calogero RA; Calabrò V; Pollice A; La Mantia G
    PLoS One; 2013; 8(1):e53631. PubMed ID: 23308265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function.
    Kowalczyk D; Nakasone MA; Smith BO; Huang DT
    Life Sci Alliance; 2022 Aug; 5(12):. PubMed ID: 35944929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2.
    Nitta RT; Smith CL; Kennedy BK
    PLoS One; 2007 Sep; 2(9):e963. PubMed ID: 17896003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2.
    van Leeuwen IM; Higgins M; Campbell J; McCarthy AR; Sachweh MC; Navarro AM; Laín S
    Mol Cancer Ther; 2013 Apr; 12(4):471-80. PubMed ID: 23416275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomerization conditions Mdm2-mediated efficient p53 polyubiquitylation but not its proteasomal degradation.
    Hjerpe R; Aillet F; Lopitz-Otsoa F; Lang V; Torres-Ramos M; Farrás R; Hay RT; Rodríguez MS
    Int J Biochem Cell Biol; 2010 May; 42(5):725-35. PubMed ID: 20080206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.
    Chen D; Kon N; Li M; Zhang W; Qin J; Gu W
    Cell; 2005 Jul; 121(7):1071-83. PubMed ID: 15989956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Mdm2 expression inhibits tumor development induced by loss of ARF.
    Wang P; Greiner TC; Lushnikova T; Eischen CM
    Oncogene; 2006 Jun; 25(26):3708-18. PubMed ID: 16491126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
    Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
    Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability.
    Tompkins VS; Hagen J; Frazier AA; Lushnikova T; Fitzgerald MP; di Tommaso A; Ladeveze V; Domann FE; Eischen CM; Quelle DE
    J Biol Chem; 2007 Jan; 282(2):1322-33. PubMed ID: 17110379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMI mediates transcription-independent ARF regulation in response to cellular stresses.
    Li Z; Hou J; Sun L; Wen T; Wang L; Zhao X; Xie Q; Zhang SQ
    Mol Biol Cell; 2012 Dec; 23(23):4635-46. PubMed ID: 23034180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.
    Wang X; Zha M; Zhao X; Jiang P; Du W; Tam AY; Mei Y; Wu M
    Nat Commun; 2013; 4():1551. PubMed ID: 23462994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
    Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
    Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway.
    Kamrul HM; Wadhwa R; Kaul SC
    Ann N Y Acad Sci; 2007 Apr; 1100():312-5. PubMed ID: 17460193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.
    Minges JT; Grossman G; Zhang P; Kafri T; Wilson EM
    J Biol Chem; 2015 Oct; 290(41):25174-87. PubMed ID: 26330556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of gastric tumorigenesis through MKRN1-mediated posttranslational regulation of p14ARF.
    Ko A; Shin JY; Seo J; Lee KD; Lee EW; Lee MS; Lee HW; Choi IJ; Jeong JS; Chun KH; Song J
    J Natl Cancer Inst; 2012 Nov; 104(21):1660-72. PubMed ID: 23104211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3 Binding to Pim-phosphorylated Ser166 and Ser186 of human Mdm2--Potential interplay with the PKB/Akt pathway and p14(ARF).
    Wood NT; Meek DW; Mackintosh C
    FEBS Lett; 2009 Feb; 583(4):615-20. PubMed ID: 19166854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.